No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
T2* relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland
1. H. D. Nelson, K. Tyne, A. Naik, C. Bougatsos, B. K. Chan, and L. Humphrey, “Screening for breast cancer: An update for the US Preventive Services Task Force,” Ann. Intern. Med. 151, 716–726 (2009).
2. S. Robinson, “Blood oxygenation level dependent (BOLD) imaging of tumors,” in New Techniques in Oncologic Imaging, A. R. Padhani and P. Choyke, eds. (Taylor & Francis, Boca Raton, 2005), pp. 257–272.
3. S. Foxley, X. B. Fan, D. Mustafi, C. Haney, M. Zamora, E. Markiewicz, M. Medved, A. M. Wood, and G. S. Karczmar, “Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images,” Magn. Reson. Med. 61, 291–298 (2009).
4. J. E. Green, M. A. Shibata, K. Yoshidome, M. L. Liu, C. Jorcyk, M. R. Anver, J. Wigginton, R. Wiltrout, E. Shibata, S. Kaczmarczyk, W. Wang, Z. Y. Liu, A. Calvo, and C. Couldrey, “The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma,” Oncogene 19, 1020–1027 (2000).
5. S. A. Jansen, S. D. Conzen, X. B. Fan, E. J. Markiewicz, G. M. Newstead, and G. S. Karczmar, “Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: A pilot study,” Breast Cancer Res. 11, p. R65 (2009).
6. S. A. Jansen, S. D. Conzen, X. Fan, T. Krausz, M. Zamora, S. Foxley, J. River, G. M. Newstead, and G. S. Karczmar, “Detection of in situ mammary cancer in a transgenic mouse model: In vitro and in vivo MRI studies demonstrate histopathologic correlation,” Phys. Med. Biol. 53, 5481–5493 (2008).
7. A. E. Holland, R. E. Hendrick, H. Jin, P. D. Russ, J. O. Barentsz, and R. Holland, “Correlation of high-resolution breast MR imaging with histopathology; Validation of a technique,” J. Magn. Reson. Imaging 11, 601–606 (2000).
8. X. B. Fan, H. Abe, M. Medved, S. Foxley, S. Arkani, M. A. Zamora, O. I. Olopade, G. M. Newstead, and G. S. Karczmar, “Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: Qualitative and quantitative comparisons,” J. Magn. Reson. Imaging 24, 1311–1315 (2006).
9. S. Foxley, X. Fan, D. Mustafi, C. Yang, M. A. Zamora, M. Medved, and G. S. Karczmar, “Quantitative analysis of water proton spectral lineshape: A novel source of contrast in MRI,” Phys. Med. Biol. 53, 4509–4522 (2008).
10. M. Medved, W. L. Du, M. A. Zamora, X. B. Fan, O. I. Olopade, P. M. MacEneaney, G. Newstead, and G. S. Karczmar, “The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast,” J. Magn. Reson. Imaging 18, 442–448 (2003).
11. H. Oikawa, H. A. AlHallaq, M. Z. Lewis, J. N. River, D. A. Kovar, and G. S. Karczmar, “Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia,” Magn. Reson. Med. 38, 27–32 (1997).
12. D. P. O’Regan, M. F. Callaghan, M. Wylezinska-Arridge, J. Fitzpatrick, R. P. Naoumova, J. V. Hajnal, and S. A. Schmitz, “Liver fat content and T2*: Simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T—Feasibility,” Radiology 247, 550–557 (2008).
13. M. Medved, G. M. Newstead, H. Abe, M. A. Zamora, O. I. Olopade, and G. S. Karczmar, “High spectral and spatial resolution MRI of breast lesions: Preliminary clinical experience,” Am. J. Roentgenol. 186, 30–37 (2006).
14. R. H. M. Bonini, D. Zeotti, L. A. L. Saraiva, C. S. Trad, J. M. S. Filho, H. H. A. Carrara, J. M. de Andrade, A. C. Santos, and V. F. Muglia, “Magnetization transfer ratio as a predictor of malignancy in breast lesions: Preliminary results,” Magn. Reson. Med. 59, 1030–1034 (2008).
Article metrics loading...
Full text loading...
Most read this month